To submit a proposal for these opportunities:
Interested candidates must send a one-page summary of their research proposal and their biosketch in pdf format via the Limited Submission Portal.
The Call for Applications for the Ludeman Family Center for Women’s Health Research Early-career Faculty Research Development Awards are due Friday, June 10, 2022.
Please address any questions to Carly Pilius or visit the website for more details.
The third Colorado Pragmatic Research in Health Conference (COPRH Con) will be held virtually May 23-25, 2022.
Ideal for clinical and translational researchers, including statisticians, dissemination and implementation scientists, health services and public health researchers and program evaluators. Junior faculty with career development awards, fellows and anyone wanting to learn and apply new methods directly from world-renowned experts are encouraged to attend.
COPRH Con 2022 offers two tracks: Pragmatic Measures & Methods track and Dissemination & Implementation Strategies track.
The 2022 theme rounds out our three-year series following the evidence life cycle, focused on dissemination, sustainability and de-implementation of pragmatic research.
Learn about topics ranging from dissemination strategies, advanced analytics, complexity and systems science and de-implementation of ineffective interventions.
For agenda and registration details please visit the website.
Learn the tools needed to translate research discoveries into patient impact at SPARK webinars.
Date: 4/20/22, 4 – 6pm
Title: MedTech Commercialization: A Roadmap for Regulated Industry
Description: We will explore healthcare technology pathways from design through the commercial phases with an emphasis on how to resolve common barriers to adoption.
Speaker: Michael L. Mestek, PhD, Director of US Marketing at Medtronic, Advisory Board Member at The Johns Hopkins Center for Bioengineering Innovation & Design External and the Board of Directors for the Colorado BioScience Institute
Date: April 27, 4 – 6pm
Title: Shining a light on the FDA black box: a nonclinical perspective
Description: This talk will describe the types of early communications with the FDA and the high level requirements for nonclinical programs supporting clinical development of 4 product types: small molecules, protein therapeutics, prophylactic vaccines and cell and gene therapies. Case studies will be provided.
Speaker: Melanie Hartsough, Independent Consultant at Hartsough Nonclinical Consulting, LLC Register here.
See the full schedule of webinars and register on the SPARK events page.
This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.